1. Home
  2. EXPI vs ADPT Comparison

EXPI vs ADPT Comparison

Compare EXPI & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPI
  • ADPT
  • Stock Information
  • Founded
  • EXPI 2008
  • ADPT 2009
  • Country
  • EXPI United States
  • ADPT United States
  • Employees
  • EXPI N/A
  • ADPT N/A
  • Industry
  • EXPI Real Estate
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EXPI Finance
  • ADPT Health Care
  • Exchange
  • EXPI Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • EXPI 1.5B
  • ADPT 1.8B
  • IPO Year
  • EXPI N/A
  • ADPT 2019
  • Fundamental
  • Price
  • EXPI $10.12
  • ADPT $11.82
  • Analyst Decision
  • EXPI Buy
  • ADPT Strong Buy
  • Analyst Count
  • EXPI 2
  • ADPT 7
  • Target Price
  • EXPI $12.00
  • ADPT $10.57
  • AVG Volume (30 Days)
  • EXPI 1.0M
  • ADPT 2.4M
  • Earning Date
  • EXPI 07-30-2025
  • ADPT 07-31-2025
  • Dividend Yield
  • EXPI 1.96%
  • ADPT N/A
  • EPS Growth
  • EXPI N/A
  • ADPT N/A
  • EPS
  • EXPI N/A
  • ADPT N/A
  • Revenue
  • EXPI $4,579,524,000.00
  • ADPT $189,527,000.00
  • Revenue This Year
  • EXPI $2.85
  • ADPT $24.46
  • Revenue Next Year
  • EXPI $4.00
  • ADPT $20.25
  • P/E Ratio
  • EXPI N/A
  • ADPT N/A
  • Revenue Growth
  • EXPI 4.83
  • ADPT 8.61
  • 52 Week Low
  • EXPI $6.90
  • ADPT $3.51
  • 52 Week High
  • EXPI $15.39
  • ADPT $12.43
  • Technical
  • Relative Strength Index (RSI)
  • EXPI 64.71
  • ADPT 63.35
  • Support Level
  • EXPI $9.30
  • ADPT $11.41
  • Resistance Level
  • EXPI $9.87
  • ADPT $12.36
  • Average True Range (ATR)
  • EXPI 0.36
  • ADPT 0.59
  • MACD
  • EXPI 0.08
  • ADPT -0.01
  • Stochastic Oscillator
  • EXPI 72.24
  • ADPT 72.65

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: